Not finding it? Sign in to also search OpenAlex live.
-
Rational use of expensive medicines in the Netherlands: strategies to improve effectiveness and reduce burden on patients and society – a narrative review2026 BMC Medicine review Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access
Bart M. F. Penninx, Sander W. Tas, Lonneke Timmers, Nicole C. A. J. van de Kar, Atse H Huisman, Denise van den Berg, +2 more
1citations -
4CPS-048 A complex, adherence-improving pharmacist intervention to reduce hyperphosphatemia in hemodialysis patients2024 Section 4: Clinical pharmacy services conference-paper Medicine Medication Adherence and Compliance Open access
Ciske van de Oever, Erwin C. Vasbinder, Teun van Gelder, Yvonne C. Schrama, Patricia M. L. A. van den Bemt
0citations -
Characterizing Thrombocytopenia in Patients with Duchenne Muscular Dystrophy Treated with Givinostat: Results from the Phase 3 EPIDYS Trial2026 Neuropediatrics conference-paper Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders
K. Gilling, L. McAdam, John Frederick Brandsema, Erika L. Finanger, F. Alessi, S. Cazzaniga, +2 more
0citations -
Feasibility and clinical outcomes of imatinib personalized dosing in gastrointestinal stromal tumor patients.2025 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Maud B. A. van der Kleij, Eline L. Giraud, Niels A.D. Guchelaar, Kim Westerdijk, Marinda Meertens, Roos F. Bleckman, +12 more
1citations -
Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort study2025 Research and Practice in Thrombosis and Haemostasis article Medicine Atrial Fibrillation Management and Outcomes Open access
Eva K Kempers, Qingui Chen, Nienke van Rein, Ferdows Atiq, Roger K. Schindhelm, Nynke M. Wiersma, +8 more
1citations -
Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type2025 Fundamental and Clinical Pharmacology article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Edwin J. Brokaar, Jonathan Emanuel Knikman, Loes E. Visser, Frederiek van den Bos, Linda M. Henricks, Carin A.T.C. Lunenburg, +9 more
4citations -
Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II Trial2026 Annals of Surgical Oncology article Medicine Intraperitoneal and Appendiceal Malignancies Open access
Teun B M van den Heuvel, Paulien Rauwerdink, Emma C. Hulshof, Vincent C. J. van de Vlasakker, Dirk Jan A. R. Moes, Giulia Pluimakers, +9 more
2citations -
Extended-Release Tacrolimus Versus LifeCycle Pharma Tacrolimus in Kidney Transplant Recipients: A Switch Study2026 Therapeutic Drug Monitoring article Medicine Renal Transplantation Outcomes and Treatments Open access
Emma H. van Schijndel, Theodora Standaar, Marloes van der Meer‐Vos, Liffert Vogt, Ron A. A. Mathôt, Jesse Joachim Swen, +4 more
0citations -
Recanalization and Stenting of the Celiac and the Superior Mesenteric Artery Supported by Use of a Steerable Introducer Sheath: Report on 2 Years’ Experience2020 Vascular and Endovascular Surgery article Medicine Abdominal vascular conditions and treatments
Federico Pedersoli, Lea Hitpaß, Peter Isfort, Markus Zimmermann, Maximilian Franz Schulze-Hagen, Alexander Gombert, +3 more
6citations -
Fixed dosing of tocilizumab in ICU admitted COVID-19 patients is a superior choice compared to bodyweight based dosing; an observational population pharmacokinetic and pharmacodynamic study
Dirk Jan A. R. Moes, David J. van Westerloo, Sandra M. Arend, Jesse Joachim Swen, Annick de Vries, Henk‐Jan Guchelaar, +4 more
3citations